Physician

Mark Tye Haeberle

According to 2025 Medicare claims, Mark Haeberle (NPI: 1558650291) practices dermatology in the Louisville/Jefferson County, KY-IN market, with the plurality of this provider's patient population coming from Floyd, IN. This provider's primary affiliated billing organization is ASSOCIATES IN DERMATOLOGY, PLLC (NPI: 1629083399; TIN: 611085679) and primary practice location at 47150-4647.

Haeberle's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,371 traditional Medicare patients, billed 5,106 HCPCS/CPT codes, and received $688,180 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 1,176 prescription claims across 476 beneficiaries totaling $1,193,418 in drug costs, led by Tremfya (Guselkumab). Open Payments data shows 33 records totaling $671. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $972 to $688,180. Similarly, Part D prescription costs have risen steadily, from $6,291 to $1,193,418. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	12	25	$972
2016	404	1,473	$63,975
2017	638	2,439	$84,307
2018	643	1,803	$243,326
2019	1,065	4,250	$542,832
2020	1,092	3,975	$537,804
2021	1,335	4,674	$614,272
2022	1,320	4,439	$714,377
2023	1,476	4,987	$677,335
2024	1,371	5,106	$688,180

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	16	49	$6,291
2016	149	326	$20,442
2017	225	752	$104,790
2018	193	311	$21,704
2019	256	556	$262,860
2020	269	710	$261,946
2021	323	791	$385,820
2022	330	829	$604,440
2023	474	1,144	$1,037,140
2024	476	1,176	$1,193,418

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17311	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks	426	524	$405
17312	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks	178	249	$298
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	416	530	$57
11102	Biopsy of related skin growth, first growth	176	214	$51
88305	Pathology examination of tissue using a microscope, intermediate complexity	526	674	$48

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tremfya	Guselkumab	26	1,512	$375,225
Erivedge	Vismodegib	17	500	$218,113
Otezla	Apremilast	21	628	$109,504
Cosentyx Sensoready (2 Pens)	Secukinumab	13	364	$93,906
Dupixent Pen	Dupilumab	26	714	$91,808

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	33	$671	Regeneron Healthcare Solutions, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mark Tye Haeberle?

Tedicare shows public-source Medicare data for Mark Tye Haeberle (NPI 1558650291), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark Tye Haeberle have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mark Tye Haeberle?

Mark Tye Haeberle is linked to ASSOCIATES IN DERMATOLOGY, PLLC (billing NPI 1629083399) in the available physician profile data.

Does Mark Tye Haeberle have Open Payments data?

Mark Tye Haeberle has 33 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.